TFIPS
UTHR icon

Towarzystwo Funduszy Inwestycyjnych PZU SA’s United Therapeutics UTHR Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.7K Buy
88
+33
+60% +$18.6K 0.01% 477
2026
Q1 		$32.6K Hold
55
– – 0.01% 524
2025
Q4 		$26.8K Hold
55
– – 0.01% 574
2025
Q3 		$23.1K Sell
55
-125
-69% -$42K 0.01% 571
2025
Q2 		$51.7K Sell
180
-110
-38% -$32.9K 0.01% 401
2025
Q1 		$89.4K Buy
290
+155
+115% +$53.1K 0.03% 250
2024
Q4 		$47.6K Sell
135
-15
-10% -$5.51K 0.02% 373
2024
Q3 		$53.8K Buy
150
+50
+50% +$16.9K 0.02% 319
2024
Q2 		$31.9K Hold
100
– – 0.01% 377
2024
Q1 		$23K Hold
100
– – 0.01% 428
2023
Q4 		$22K Buy
+100
New +$23K 0.01% 417

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's UTHR Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its United Therapeutics (UTHR) stake by 60% in Q2 2026, buying an estimated $18.6K and bringing the position to 88 shares worth $47.7K. The position accounts for 0.01% of the portfolio, ranked #477.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in UTHR in Q4 2023 and has held it in 11 quarters since. The position peaked at $89.4K in Q1 2025. 559 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA held 88 shares of United Therapeutics worth $47.7K as of Q2 2026.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA bought 33 United Therapeutics shares in Q2 2026, an estimated $18.6K.
  • United Therapeutics made up 0.01% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #477 holding.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in United Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA's United Therapeutics position peaked at $89.4K in Q1 2025.
  • 559 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.